PA
CBC

PharVision Advisers’s Central Bancompany Inc CBC Stock Holding History

PharVision Advisers’s Portfolio CBC Stock Details CBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16,076
Closed -$388K – 707
2025
Q4 		$388K Buy
+16,076
New +$378K 0.2% 140

Other funds holding CBC

CTC
Central Trust Company Jefferson City, Missouri $5.08B AUM 25.65% 1-Year Est. Return
NRCM
North Reef Capital Management Laguna Beach, California $2.91B AUM 11.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PharVision Advisers's CBC Position: Q1 2026 in Review

PharVision Advisers sold out of Central Bancompany Inc (CBC) in Q1 2026, closing a stake of 16,076 shares — an estimated $388K sold.

PharVision Advisers first reported a position in CBC in Q4 2025 and held it in 1 quarter. The position peaked at $388K in Q4 2025. 102 funds tracked by Wall St. Rank hold CBC as of Q1 2026.

  • PharVision Advisers reported no remaining Central Bancompany Inc position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 16,076 Central Bancompany Inc shares in Q1 2026, an estimated $388K.
  • PharVision Advisers first reported a position in Central Bancompany Inc in Q4 2025 and held it in 1 quarter.
  • PharVision Advisers's Central Bancompany Inc position peaked at $388K in Q4 2025.
  • 102 funds tracked by Wall St. Rank held Central Bancompany Inc as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.